http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60304726-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf1f985f82d66610141d4f1c5307145c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee06c38b8ca03c707802a99aaba07d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e559dcb0a6deacb9c8bd999577fa8715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38ebcb0b453f8f27b78814c9a458f7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a5df1249dd4cd962de910ea71fbf97
publicationDate 2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60304726-T2
titleOfInvention BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PRODRUGS FOR PROTONAL PUMP INHIBITORS
abstract Prodrugs of proton pump inhibitors of Formulas 1 through 4, where the symbols are as defined in the specification, and the R group includes at least one acidic group or its pharmaceutically acceptable salt, have improved aqueous solubility and bioavailability.
priorityDate 2002-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457191321
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A3P9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467923482
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB9GCH9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467013121
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466998626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467812904
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS22
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467007333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468297219
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE0ZS48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SR52
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS23
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467739225
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468038281
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467882443

Total number of triples: 55.